LLY vs BMY Comparison
Compare financials and metrics between Eli Lilly and Company (LLY) and Bristol-Myers Squibb Company (BMY)
Stock Comparison
| Metric | LLY | BMY |
|---|---|---|
| Market Cap | $838.5 B | $97.5 B |
| Gross Margin | 82% | 61% |
| Profit Margin | 33% | 1% |
| EBITDA margin | 45% | 21% |
| Quarterly Revenue | $13.5 B | $12.3 B |
| Quarterly Earnings | $4.4 B | $72.0 B |
| Quarterly Free Cash Flow | $0 B | $4.1 M |
| Trailing 4 Quarters Revenue | $45.0 B | $48.3 B |
| Trailing 4 Quarters Earnings | $10.6 B | -$8.9 B |
| Quarterly Earnings Growth | 101% | -96% |
| Annual Earnings Growth | 425% | -219% |
| Quarterly Revenue Growth | 45% | 8% |
| Annual Revenue Growth | 19% | 9% |
| Cash On Hand | $0 | $10.3 B |
| Short Term Debt | $0 | $2.2 B |
| Long Term Debt | $0 | $49.0 B |
| PE | 79.18 | -1.00 |
| PS | 18.62 | 2.02 |
| PB | 58.55 | 5.95 |
| PC | -1.00 | 9.42 |
| Liabilities to Equity | -1.00 | 4.67 |
| ROA | -100% | -10% |
| ROE | 74% | -55% |
| Current Ratio | 0.00 | 1.22 |
| Quick Ratio | -0.25 | 0.14 |
| Long Term Debt to Equity | 0.00 | 3.00 |
| Debt to Equity | 0.00 | 3.13 |
| Burn Rate | 0.00 | 4.23 |
| Cash to Cap | 0.00 | 0.11 |
| CCR | 0.00 | 56.40 |
| EV to EBITDA | 136.37 | 54.22 |
| EV to Revenue | 18.62 | 2.86 |